Peptides DB
Research-centric peptide and protocol reference hub
Study 10 of 10Triptorelin literatureEuropean journal of obstetrics, gynecology, and reproductive biology · Meta-analysis2026

Comparative effectiveness of luteal phase support strategies in natural cycle frozen-thawed embryo transfer: a systematic review and network meta-analysis.

Luteal phase support may improve pregnancy outcomes in natural cycle frozen-thawed embryo transfer, but the evidence is not strong enough to make definitive recommendations.

Read at European journal of obstetrics, gynecology, and reproductive biologyAdd to compare

Where it sits

this study against the rest of the triptorelin corpus
0
Preclinical
8
Observational
0
Open-label
1
Randomised
1
Reviews · this one

Summary and findings

This study evaluated the effectiveness of luteal phase support (LPS) strategies in natural cycle frozen-thawed embryo transfer (NC-FET). It included data from twenty studies, with a focus on clinical pregnancy rates (CPR) and live birth rates (LBR). The findings suggest LPS may improve outcomes compared to no LPS, but definitive conclusions are limited by the quality of evidence.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as European journal of obstetrics, gynecology, and reproductive biology supplied them

<h4>Aim</h4>Luteal phase support (LPS) may improve pregnancy outcomes in natural cycle frozen-thawed embryo transfer (NC-FET), though the comparative effectiveness of different regimens remains uncertain. This network meta-analysis (NMA) was conducted as an exploratory synthesis.<h4>Methods</h4>A systematic search of PubMed, EMBASE, and the Cochrane Library was conducted through March 2026. We performed pairwise meta-analyses using Review Manager 5.3 and exploratory network meta-analyses with Stata 14.0. We assessed certainty of evidence using the CINeMA framework.<h4>Results</h4>Twenty studies (8 RCTs, 12 retrospective studies) were included. Pairwise meta-analyses suggested LPS was associated with improved clinical pregnancy rate (CPR) and live birth rate (LBR) compared with no LPS, with no apparent increase in miscarriage rate (MR). The RCT-only NMA could not be performed because the network was disconnected, with no closed loops among the 8 RCTs, reflecting the current lack of head-to-head randomized evidence for LPS regimen selection in NC-FET. In the exploratory full-network analysis, VP + triptorelin + hCG showed a relatively high surface under the cumulative ranking curve (SUCRA) for CPR, and VP + triptorelin for LBR.<h4>Conclusion</h4>LPS was associated with improved pregnancy outcomes in NC-FET. The RCT-only network was too sparse to support valid rankings. While VP + triptorelin ( ± hCG) showed relatively high SUCRA values for CPR and LBR, the very low certainty of evidence precludes definitive conclusions.

Background

This paper addresses the clinical question of how different luteal phase support (LPS) strategies affect pregnancy outcomes in natural cycle frozen-thawed embryo transfer (NC-FET). Previous studies have indicated that LPS may improve outcomes, but the comparative effectiveness of various regimens remains unclear. This systematic review and network meta-analysis aim to synthesize existing evidence to inform clinical practice.

Methods

A systematic search of PubMed, EMBASE, and the Cochrane Library was conducted through March 2026. The analysis included 20 studies, comprising 8 randomized controlled trials (RCTs) and 12 retrospective studies. Pairwise meta-analyses and exploratory network meta-analyses were performed using Review Manager 5.3 and Stata 14.0, respectively.

Results

The analysis suggested that LPS was associated with improved clinical pregnancy rates and live birth rates compared to no LPS, with no significant increase in miscarriage rates. However, the RCT-only network was disconnected, limiting the ability to perform valid rankings among LPS regimens. In the exploratory full-network analysis, VP + triptorelin + hCG showed a relatively high surface under the cumulative ranking curve (SUCRA) for clinical pregnancy rate.

Interpretation

The findings suggest a potential benefit of LPS in improving pregnancy outcomes, but the low certainty of evidence and disconnected RCT network limit the strength of these conclusions. The effect sizes observed may not be clinically meaningful given the uncertainty. Practitioners should be cautious in interpreting these results due to the methodological limitations and the lack of robust head-to-head evidence.

Key findings

  • LPS associated with improved clinical pregnancy rate (CPR) and live birth rate (LBR) compared with no LPS.
  • No apparent increase in miscarriage rate (MR) with LPS.
  • RCT-only network was disconnected, preventing valid rankings among LPS regimens.
  • VP + triptorelin + hCG showed relatively high surface under the cumulative ranking curve (SUCRA) for CPR.
  • VP + triptorelin showed relatively high SUCRA values for LBR.
  • Very low certainty of evidence precludes definitive conclusions.

Limitations

  • Low certainty of evidence.
  • RCT-only network was disconnected.
  • Includes retrospective studies.
  • No closed loops among RCTs.
  • Exploratory analysis with limited definitive conclusions.

Elsewhere in the Triptorelin corpus

CProposed Method for Mass Spectrometric Measurement of the Gonadotropin-Releasing Hormone Agonist Deslorelin.Toxics · 2026 · Detectability optimized to <1 ppb.AnimalBComparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study.Urologic oncology · 2026 · n=6666 · HR for MACE with LHRH-AG vs LHRH-AN was 0.86, 95% CI: 0.79-0.93.HumanAEvaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.BJU international · 2026 · n=88 · Not reported in abstract.HumanBOptimizing ovarian stimulation in oocyte donation: exploratory comparison of rhFSH (2:1) versus hp-hMG under PPOS protocols.JBRA assisted reproduction · 2023 · n=36 · Mean number of good-morphology blastocysts per cycle was 4.5 with rhFSH:rhLH vs 2.0 with hp-hMG.HumanBTreatment Outcomes in 84 Male Children with Accelerated Pubertal Progression: A Comparative Analysis ofGnRHa, Combined GH Therapy and Aromatase Inhibitorbiorxiv-preprint · 2026 · ΔH/y of combination therapy was 8.49 ± 3.22 cm/y, GnRHa was 6.73 ± 1.95 cm/y, and AI was 7.75 ± 1.92 cm/y, P < 0.01.HumanBPerceived Stress During Gender-Affirming Hormone Therapy: A Comparative Study of Feminizing and Masculinizing Hormone Therapy in an International Multicenter Prospective Cohortbiorxiv-preprint · 2025 · No significant changes in perceived stress were observed after 3 months (-1.0, p = 0.21).Human